Publications & Works

Publication Network
Articles 89
All (89)
SCI-E, SSCI, AHCI (56)
SCI-E, SSCI, AHCI, ESCI (81)
ESCI (23)
Scopus (69)
TRDizin (33)

1. Posaconazole Therapeutic Drug Monitoring in Daily Practice: A Single-Center Analysis

Balaban U., Kara E., Pinar A., Gülmez Kıvanç D., Karakulak E. A., Akdagli S. A., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.42, pp.818-825, 2026 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

2. Clinical pharmacist-led implementation of an intravenous-to-oral antimicrobial switch protocol: A prospective Quasi-experimental study

Yumrucu F. G., KARA E., YUMRUKAYA L., ZENGİN H. Y., YEĞENOĞLU S., İNKAYA A. Ç., et al.
Journal of Infection and Chemotherapy , vol.32, no.3, 2026 (SCI-Expanded, Scopus) identifier identifier

3. Impact of pharmacist-led interventions on economic, clinical, and humanistic outcomes (ECHO) in patients admitted to emergency departments: A systematic review of randomized controlled trials.

Kara E., Okuyan B., Goncuoglu C., Demirkan K., Sun S.
Research in social & administrative pharmacy : RSAP , vol.22, no.2, pp.222-231, 2026 (SSCI, Scopus) identifier

4. Pharmacist involvement in antifungal stewardship programs: a systematic review of clinical, utilization, and economic outcomes

KARA E., Sahin N., Yumrucu F. G., METAN G.
International Journal of Clinical Pharmacy , 2026 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

5. Medication optimization in older people living with HIV: a multidisciplinary approach

BALLI TURHAN F. N., KARA E., Sahiner Z., BALCI C., SÖNMEZER M. Ç., İNKAYA A. Ç., et al.
HIV MEDICINE , vol.26, pp.507-508, 2025 (SCI-Expanded, Scopus) identifier

6. In reply to the letter to the editor regarding 'battle of polymyxin induced nephrotoxicity: Polymyxin B versus colistin

BALLI TURHAN F. N., Ekinci P. B., Kurtaran M., KARA E., TELLİ DİZMAN G., SÖNMEZER M. Ç., et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS , vol.66, no.4, 2025 (SCI-Expanded, Scopus) identifier identifier

7. A multidisciplinary approach to enhance quality of life in older people living with HIV: a comparative study

BALLI TURHAN F. N., KARA E., Sahiner Z., BALCI C., SÖNMEZER M. Ç., İNKAYA A. Ç., et al.
HIV MEDICINE , vol.26, pp.533-534, 2025 (SCI-Expanded, Scopus) identifier

8. Therapeutic drug monitoring in patients treated with vancomycin: a single center, prospective, observational, real-world study

Dogan C. Z., KARA E., PINAR A., DEMİRKAN S. K., METAN G.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.44, no.9, pp.2159-2165, 2025 (SCI-Expanded, Scopus) Sustainable Development identifier identifier

9. Beyond conventional dosing: tailoring antimicrobial regimens for cachexia

KILINÇ E. E., BAYRAKTAR ALKAN İ., KARA E., DEMİRKAN S. K., AKOVA M.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY , vol.32, no.5, pp.491-492, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

10. Turkish translation and cultural adaptation of the Ascertaining Barriers to Compliance taxonomy for medication adherence

Goncuoglu C., KARA E., CEYLAN C., AY N. P., SANCAR M., OKUYAN B.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , 2025 (SCI-Expanded, Scopus) identifier identifier

11. An Evaluation of Physicians’ and Pharmacists’ Knowledge, Attitudes and Behaviours About Pharmacovigilance: Cross-Sectional Study

Yıldırım S., Geridönmez Ö., Kara E.
Literatür Eczacılık Bilimleri Dergisi , vol.14, no.1, pp.8-16, 2025 (TRDizin) identifier

12. TURKISH TRANSLATION AND CULTURAL ADAPTATION OF THE ORIGINAL ABC TAXONOMY FOR MEDICATION ADHERENCE: PRELIMINARY FINDINGS

Goncuoglu C., KARA E., Ceylan C., AY N. P., SANCAR M., OKUYAN B.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.47, no.2, pp.560, 2025 (SCI-Expanded, Scopus) identifier

13. CLINICAL PHARMACISTS' ASSESSMENT OF DRUG-RELATED PROBLEMS IN PATIENTS USING ANTIMICROBIALS

Geridonmez O., KARA E., UZUN Ö., DEMİRKAN S. K.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.47, no.2, pp.520-521, 2025 (SCI-Expanded, Scopus) identifier

14. IMPACT OF PHARMACIST-LED INTERVENTIONS IN PATIENTS ADMITTED TO EMERGENCY DEPARTMENTS: A SYSTEMATIC REVIEW

KARA E., OKUYAN B., Goncuoglu C., Demirkan K., Sun S.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.47, no.2, pp.500, 2025 (SCI-Expanded, Scopus) identifier

15. INTRAVENOUS-TO-ORAL SWITCH IN ANTIMICROBIAL THERAPY: A SINGLE-CENTER, OBSERVATIONAL STUDY

Yumrucu F. G., KARA E., İNKAYA A. Ç., METAN G., UZUN Ö.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.47, no.2, pp.499, 2025 (SCI-Expanded, Scopus) identifier

16. EVALUATION OF ANTIMICROBIAL DOSES USING POINT PREVALENCE AT DIFFERENT TIME POINTS

Kucukyildiz B., KARA E., UZUN Ö.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.47, no.2, pp.505, 2025 (SCI-Expanded, Scopus) identifier

17. Management of Infections Caused by Stenotrophomonas maltophilia: A Traditional Review

Gul Yumrucu F., KARA E., TELLİ DİZMAN G., İNKAYA A. Ç., DEMİRKAN S. K., METAN G.
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.30, no.1, pp.1-10, 2025 (ESCI, TRDizin) Creative Commons License identifier identifier

18. Comparison of piperacillin-tazobactam and vancomycin (TZP-VAN) with piperacillin-tazobactam and teicoplanin (TZP-TEI) for the risk of acute kidney injury (CONCOMITANT): A prospective observational, multinational, multi-centre cohort study

Aslan A. T., KARA E., Koksal G., Bilir Y., Saracoglu K. T., ESER F., et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS , no.3, 2025 (SCI-Expanded, Scopus) identifier identifier

19. Intentions of hospital pharmacists to use digital technology in their daily practice: a cross-sectional survey using the Theory of Planned Behaviour

TECEN YÜCEL K., Ozdemir-Ayduran N., KARA E., Demirkan K., OKUYAN B.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , 2025 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

20. The impact of the COVID-19 on the antifungal consumption and antifungal resistance in Candida species isolated from the blood cultures of critically ill patients in intensive care units

KARA E., METAN G., Guelmez D., Arikan-Akdagli S.
MEDICAL MYCOLOGY , vol.63, no.2, 2025 (SCI-Expanded, Scopus) Sustainable Development identifier identifier

21. Examination of drug removal profiles in patients undergoing therapeutic plasma exchange: A retrospective study

Balaban U., Kara E., Mahmoud S. H., Özcebe O. İ., Demirkan S. K.
THERAPEUTIC APHERESIS AND DIALYSIS , vol.28, no.6, pp.954-963, 2024 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

22. Monitoring of the cerebrospinal fluid voriconazole level in a patient with recurrent Candida meningitis after pituitary surgery

Üçdal M. T., Kara E., Berker M., Pınar A., Gulmez D., Arikan-Akdagli S., et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS , vol.64, no.6, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

23. Effect of therapeutic plasma exchange on antimicrobials in critically ill patients

Balaban U., Kara E., Kaya E. K., Özcebe O. İ., Akova M., Topeli İskit A., et al.
CRITICAL CARE , vol.28, no.1, 2024 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

24. Antimicrobial management in patients undergoing therapeutic plasma exchange: A Cross-Sectional Nationwide Survey

Balaban U., Kara E., Pınar A., Özcebe O. İ., Demirkan S. K., Ünal S.
JOURNAL OF INVESTIGATIVE MEDICINE , vol.72, no.8, pp.920-929, 2024 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

25. Drug Burden and Deprescribing in People Living with HIV

TURHAN F. N. B., KARA E., İNKAYA A. Ç., DEMİRKAN K., ÜNAL S.
Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi , vol.29, no.3, pp.313-324, 2024 (ESCI, TRDizin) identifier identifier

26. Cefepime Related Neurological Complications in a Dialysis Patient: A Case Report

BAYRAKTAR ALKAN İ., Muderrisoglu T., KARA E., UZUN Ö.
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.29, no.3, pp.398-402, 2024 (ESCI, TRDizin) Creative Commons License identifier identifier

27. Inhaled Aviptadil is a new hope for recovery of lung damage due to COVID-19

Esendagli D. R., Sari N., AKHAN S., ARSLAN S., Yilmaz G., AKSOY F., et al.
EUROPEAN RESPIRATORY JOURNAL , 2024 (SCI-Expanded, Scopus) identifier

28. Psychiatrists’ and Infectious Disease Physicians’ Awareness and Knowledge Level of Drug-Drug Interactions Between Antiretrovirals and Psychotropics: A Comparative Questionnaire-Based Study

YALÇIN N., İNKAYA A. Ç., KARA E., BAŞAR K., KARADAĞ Ö., DEMİRKAN S. K., et al.
FABAD JOURNAL OF PHARMACEUTICAL SCIENCES , vol.49, no.2, pp.333-344, 2024 (Scopus, TRDizin)

29. Tigecycline-associated hypofibrinogenemia: A single center, retrospective, controlled study

FIRAT O., KARA E., MALKAN Ü. Y., Demirkan K., İNKAYA A. Ç.
Thrombosis Research , vol.236, pp.155-160, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

30. Compliance with guideline recommendations in the management of patients with hospitalized community-acquired pneumonia

BAKIR EKİNCİ P., KARA E., TELLİ DİZMAN G., Metin S., İNKAYA A. Ç., Demirkan K., et al.
Journal of Investigative Medicine , vol.72, no.4, pp.349-358, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

31. Battle of polymyxin induced nephrotoxicity: Polymyxin B versus colistin.

BALLI TURHAN F. N., Ekinci P. B., Kurtaran M., KARA E., Dizman G., SÖNMEZER M. Ç., et al.
International journal of antimicrobial agents , vol.63, no.2, pp.107035, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

32. Deprescribing in the Treatment of Infectious Diseases: Traditional Review

KARAKAYA K. N., KARA E., DEMİRKAN S. K.
Journal of Literature Pharmacy Sciences , vol.13, 2024 (TRDizin) identifier

33. Evaluation of infectious diseases physicians' attitudes to dyslipidemia management in PLWH

BALLI TURHAN F. N., KARA E., UYAROĞLU O. A., ÇALIK BAŞARAN N., DEMİRKAN S. K., ÜNAL S., et al.
POSTGRADUATE MEDICINE , vol.136, pp.720-725, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

34. Initial Empirical Antibiotic Treatment in Covid-19 Patients is Related with Excess Adverse Drug Reactions Without Clinical Benefit

BAKIR EKİNCİ P., KARA E., TELLİ DİZMAN G., SÖNMEZER M. Ç., İNKAYA A. Ç., DEMİRKAN S. K., et al.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.0, 2023 (ESCI, Scopus, TRDizin) identifier identifier identifier

35. Factors associated with intention of clinical pharmacists and candidates to provide pharmaceutical care: application of theory planned behaviour

Tecen-Yucel K., ÖZDEMİR N., KARA E., Demirkan K., SANCAR M., OKUYAN B.
BMC Medical Education , vol.23, no.1, 2023 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier identifier identifier

36. Definition and prevalence over the years of polypharmacy in Turkey: A systematic review

GONCUOGLU C., OZDEMIR N., KARA E., EKINCIOGLU A. B.
Journal of research in pharmacy (online) , vol.27, no.4, pp.1474-1487, 2023 (ESCI, Scopus, TRDizin) Creative Commons License identifier identifier identifier

37. Nitroimidazole Derivative Antimicrobial Drugs and Liver Injury

Balaban U., İnkaya A. Ç., Kara E.
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.28, no.3, pp.313-320, 2023 (ESCI, TRDizin) Creative Commons License Sustainable Development identifier identifier

38. A retrospective study: Can dual ART mitigate the risk of potential drug-drug interactions among PLWH under stable ART?

İNKAYA A. Ç., BALLI F. N., KARA E., Demirkan K., ÜNAL S.
Turkish Journal of Medical Sciences , vol.53, no.5, pp.1505-1511, 2023 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier identifier

39. Development of a Theory Planned Behavior based scale to assess Turkish clinical pharmacists' intention to provide pharmaceutical care

AYDURAN N., Tecen-Yucel K., KARA E., Demirkan K., SANCAR M., OKUYAN B.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.44, no.6, pp.1487, 2022 (SCI-Expanded, Scopus) identifier

40. Can dual ART mitigate the risk of potential drug-drug interactions among people living with human immunodeficiency virus under stable ART?

BALLI TURHAN F. N., KARA E., İNKAYA A. Ç., Demirkan K., Unal S.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.44, no.6, pp.1547-1548, 2022 (SCI-Expanded, Scopus) Sustainable Development identifier

41. Drug-related problems in internal medicine wards

Bahap M., Kurtaran M., Bakir-Ekinci P., KARA E., Sain-Guven G., Oz S. G., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.44, no.6, pp.1527, 2022 (SCI-Expanded, Scopus) identifier

42. Does information by pharmacists convince the public to get vaccinated for pneumococcal disease and herpes zoster?

Bayraktar-Ekincioglu A., KARA E., Bahap M., CANKURTARAN M., Demirkan K., ÜNAL S.
IRISH JOURNAL OF MEDICAL SCIENCE , vol.191, no.5, pp.2193-2200, 2022 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

43. Knowledge, attitudes, and practices regarding vaccination among community pharmacists

ÖZDEMİR N., KARA E., Bayraktar-Ekincioglu A., BÜYÜKCAM A., ÇELİKER A., Demirkan K., et al.
PRIMARY HEALTH CARE RESEARCH AND DEVELOPMENT , vol.23, 2022 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

44. Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels

Bakir Ekinci P., KARA E., ER A. G., İNKAYA A. Ç., Demirkan K., UZUN Ö.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.88, no.3, pp.1387-1391, 2022 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

45. Blood Level Monitoring of Antimicrobial Drugs in Intensive Care Patients

Bostanci Y., KARA E., Demirkan K., TOPELİ İSKİT A., ÜNAL S.
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.27, no.1, pp.1-10, 2022 (ESCI, TRDizin) Creative Commons License Sustainable Development identifier identifier

46. Voriconazole Therapeutic Drug Level Monitoring: A University Hospital Experience

KARA E., BAKIR EKİNCİ P., METAN G., EKİNCİOĞLU A., PINAR A., AKOVA M., et al.
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.27, no.1, pp.183-188, 2022 (ESCI, TRDizin) Creative Commons License identifier identifier

47. Integrase inhibitor-based regimens are related to favorable systemic inflammatory index and platecrit scores in people living with HIV (PLWH) up to 2 years

Sahin E. A., Mavi D., KARA E., SÖNMEZER M. Ç., İNKAYA A. Ç., ÜNAL S.
POSTGRADUATE MEDICINE , vol.134, no.6, pp.635-640, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

48. Asymptomatic Eosinophilia Induced by Systemic Colistin Therapy: A Brief Case Report

BAYRAKTAR ALKAN İ., KARA E., SÖNMEZER M. Ç., DEMİRKAN S. K., TOPÇUOĞLU M. A.
Türkiye Klinikleri Journal of Case Reports , vol.30, no.1, 2022 (TRDizin) identifier

49. Approaches of the Physicians on COVID-19 Vaccination: An Online Survey from Turkiye

DOĞAN C. Z., Yucel K. T., KARA E., KAYNAR E. K., Demirkan K., ÜNAL S.
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.27, no.3, pp.453-465, 2022 (ESCI, TRDizin) Creative Commons License Sustainable Development identifier identifier

50. Evaluation of medication errors in pediatric patients using antibiotics

Ozdemir N., KARA E., Buyukcam A., AYKAÇ K., Celiker A., Demirkan K., et al.
TURKISH JOURNAL OF PEDIATRICS , vol.63, no.6, pp.970-977, 2021 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier identifier

51. Antiretroviral therapy causes a reduction in T-cell exhaustion, which is preserved after switching to a new therapy regimen

Ozcan B. B., Tavukcuoglu E., Kara E., Horzum U., Ayan G., Sonmezer M. C., et al.
HIV MEDICINE , vol.22, pp.52-53, 2021 (SCI-Expanded, Scopus) identifier

52. Implementation of Pharmacist-Driven Antifungal Stewardship Program in a Tertiary Care Hospital

KARA E., METAN G., Bayraktar-Ekincioglu A., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S., DEMİRKAZIK F., et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , vol.65, no.9, 2021 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

53. A case report of tigecycline induced acute pancreatitis in a renal transplant patient and review of the literature: Should we avoid tigecycline in patients on calcineurin inhibitors?

YAZIRLI B., KARA E., İNKAYA A. Ç., MADEN S., ÖZBERK U., YILDIRIM T., et al.
TRANSPLANT INFECTIOUS DISEASE , vol.23, no.4, 2021 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

54. Impact of Clinical Pharmacist-led Interventions in Turkey

KARA E., cakir B. K., SANCAR M., DEMİRKAN S. K.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.18, no.4, pp.517-526, 2021 (ESCI, Scopus, TRDizin) Creative Commons License Sustainable Development identifier identifier identifier identifier

55. Should prolonged ceftriaxone infusions be preferred in septic patients?

Kara E., Bahap M., Inkaya A. Ç.
The American journal of emergency medicine , vol.44, pp.474-475, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

56. Pharmacist intervention to improve patients' knowledge and attitude towards hepatitis B infection

Bahap M., Kara E., Sonmezer M. C., Inkaya A. Ç., Aydin-Hakli D., Unal S., et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, no.4, 2021 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

57. A Question Awaiting Answer During the Development and Implementation Stage of Clinical Pharmacy Services in Turkey: Who is Clinical Pharmacist?

KARA E., OKUYAN B., DEMİRKAN S. K., SANCAR M.
Literatür Eczacılık Bilimleri Dergisi , vol.10, no.1, pp.109-118, 2021 (TRDizin) identifier

58. Might Confounding Factors Have an Effect on Suboptimal Dosing of Fluconazole in Critically Ill Patients?

Kara E., Bayraktar Ekincioglu A., Metan G.
Antimicrobial agents and chemotherapy , vol.65, 2021 (SCI-Expanded, Scopus) identifier identifier

59. Favipiravir Use in COVID-19 Treatment

KARA E., İNKAYA A. Ç., Demirkan K., ÜNAL S.
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.26, no.1, pp.1-11, 2021 (ESCI, TRDizin) Creative Commons License Sustainable Development identifier identifier

60. Investigation and Comparison of Diagnosis and Treatment Guidelines for Community Acquired Pneumonia in terms of Pharmaceutical Care Requirements

Bahap M., KARA E., ER A. G., Demirkan K., ÜNAL S.
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.26, no.1, pp.50-66, 2021 (ESCI, TRDizin) Creative Commons License Sustainable Development identifier identifier

61. Effects of Cytochrome p450 (CYP) 2C19 Genetic Polymorphisms on Voriconazole Serum Levels: A Report of Two Cases

TAŞ Z., KARA E., DEĞER O., İspirli M., METAN G., BABAOĞLU M. Ö., et al.
Mediterranean Journal of Infection, Microbes and Antimicrobials , vol.10, 2021 (Scopus) identifier identifier

62. Pretreatment serum uric acid level is not a surrogate marker for the outcome of favipiravir treatment in COVID-19 patients

İNKAYA A. Ç., KARA E., ÇALIK BAŞARAN N., ŞAHİN T. K., UYAROĞLU O. A., UZUN Ö., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.5, pp.2786-2788, 2021 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sustainable Development identifier identifier identifier

63. Knowledge and attitudes of pharmacy students about COVID-19

KARA E., ÖZDEMİR N., TELLİ DİZMAN G., Demirkan K., ÜNAL S.
JOURNAL OF RESEARCH IN PHARMACY , vol.25, no.6, pp.898-904, 2021 (ESCI, TRDizin) Creative Commons License Sustainable Development identifier identifier identifier

64. An Evaluation of Information Sources Regarding Drug Use and/or Poisoning Cases of Community Pharmacists in Ankara, Turkey

ÇELİKER A., KARA E., KARAHAN S.
Acta Medica , 2021 (TRDizin)

65. Colistin Induced Nephrotoxicity: Experience from a University Hospital

Bakır Ekinci P., Kurtaran M., Kara E., Avcı H., Demirkan S. K., Metan G.
Mediterranean Journal of Infection Microbes and Antimicrobials , vol.10, 2021 (Scopus) Creative Commons License identifier identifier

66. Hypersensitivity Reactions to Beta-lactam Antibiotics

Goncuoglu C., KARA E., Demirkan K., KALYONCU A. F., ÜNAL S.
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.26, no.1, pp.23-33, 2021 (ESCI, TRDizin) Creative Commons License identifier identifier

67. Fighting on two fronts: drug-drug interactions in people living with HIV infected with SARS-CoV-2.

Bahap M., Kara E., Sain Guven G.
European journal of hospital pharmacy : science and practice , vol.28, 2021 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

68. COVID-19 HAKKINDA ECZACILARIN VE ECZACILIK ÖĞRENCİLERİNİN BİLGİ VE TUTUMLARI

KARA E., DEMİRKAN S. K., ÜNAL S.
İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi , vol.8, no.3, pp.763-778, 2020 (TRDizin) Sustainable Development

69. The Another Side of COVID-19 in Alzheimer's Disease Patients: Drug-Drug Interactions.

Balli N., Kara E., Demirkan K.
International journal of clinical practice , vol.74, 2020 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

70. Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19.

Kara E., Demirkan K., Unal S.
International journal of antimicrobial agents , vol.56, 2020 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

71. Evaluation of internal medicine physicians’ attitudes toward the treatment of dyslipidemia

Kara E., Tecen Y., Bayraktar-Ekincioglu A., Demirkan K., Tokgozoglu L., Unal S.
Postgraduate Medicine , vol.132, no.6, pp.538-543, 2020 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

72. The Impact of The Clinical Pharmacist‐Led Interventions in Turkey

KARA E., KELLECİ ÇAKIR B., SANCAR M., DEMİRKAN S. K.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.0, no.0, 2020 (ESCI, Scopus, TRDizin)

73. May drug-related cardiovascular toxicities persist after hospital discharge in COVID-19 patients?

Kara E., Inkaya A. Ç., Demirkan K.
International journal of antimicrobial agents , vol.55, pp.106003, 2020 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

74. Knowledge and Attitudes Among Hospital Pharmacists About COVID-19

KARA E., DEMİRKAN S. K., ÜNAL S.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.17, no.3, pp.242-248, 2020 (ESCI, Scopus, TRDizin) Creative Commons License Sustainable Development identifier identifier identifier

75. Cerrahi Alan İnfeksiyonlarının Profilaksisinde Lokal Vankomisin Uygulaması

KARA E., Bahap M., İNKAYA A. Ç., DEMİRKAN S. K., TOKGÖZOĞLU A. M., ÜNAL S.
FLORA-INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.25, no.1, pp.19-27, 2020 (ESCI, TRDizin)

76. Local Vancomycin Usage for Prophylaxis of Surgical Site Infections

KARA E., BAHAP M., İNKAYA A. Ç., DEMİRKAN S. K., TOKGÖZOĞLU A. M., ÜNAL S.
FLORA-INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.25, no.1, pp.19-27, 2020 (ESCI, TRDizin) identifier

77. Cross-Reactivity to Meropenem and Ertapenem Without Imipenem

BAKIR P., KARA E., DEMİRKAN S. K., UZUN Ö.
Dahili ve Cerrahi Bilimler Yoğun Bakım Dergisi , vol.11, no.1, pp.28-30, 2020 (ESCI, Scopus, TRDizin)

78. Knowledge and Attitudes of Hospital Pharmacist About COVID-19

KARA E., DEMİRKAN S. K., ÜNAL S.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , 2020 (ESCI, Scopus, TRDizin) Sustainable Development

79. The use of Hydroxychloroquine in the Treatment of COVID-19

Tecen-Yucel K., KARA E., Demirkan K., ÜNAL S.
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.25, no.3, pp.283-291, 2020 (ESCI, TRDizin) Creative Commons License Sustainable Development identifier

80. Yoğun Bakım Hastalarında Antibiyotiklerin Diğer İlaçlarla Etkileşimlerinin Değerlendirilmesi

KARA E., TECEN YÜCEL K., ÖZDEMİR N., İNKAYA A. Ç., EKİNCİOĞLU A., DEMİRKAN S. K., et al.
STED/Sürekli Tıp Eğitimi Dergisi , vol.28, no.6, pp.404-409, 2019 (TRDizin) Creative Commons License

81. Polypharmacy and drug-related problems among people living with HIV/AIDS: a single-center experience

Kara E., İnkaya A. Ç., Aydın Haklı D., Demirkan S. K., Ünal S.
Turkish Journal Of Medical Sciences , vol.49, no.1, pp.222-229, 2019 (SCI-Expanded, Scopus, TRDizin) identifier

82. Evaluation of potential drug drug interactions on antiretroviral treatment

KARA E., İNKAYA A. Ç., Ozdemir N., Bayraktar-Ekincioglu A., Demirkan K., ÜNAL S.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.40, no.1, pp.307, 2018 (SCI-Expanded, Scopus) identifier

83. Evaluation of drugs used in paediatric bone marrow transplantation unit in terms of drug interactions

Ozdemir N., Tecen K., KARA E., ÇELİKER A., OKUR F. V., KUŞKONMAZ B. B., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.40, no.1, pp.274, 2018 (SCI-Expanded, Scopus) identifier

84. Are physicians confused in the management of dyslipidemia?

Tecen K., KARA E., Ecemis S., ARAS E., Ozdemir N., Bayraktar-Ekincioglu A., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.40, no.1, pp.281-282, 2018 (SCI-Expanded, Scopus) identifier

85. Drug-drug interactions in intensive care unit: A point prevalence study

Bahap M., KARA E., Bayraktar-Ekincioglu A., Topeli A., Demirkan K.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.40, no.1, pp.307, 2018 (SCI-Expanded, Scopus) identifier

86. Influence of the clinical pharmacy postgraduate education program students in intensive care units

Tecen K., Surmelioglu N., Uysal C., ÖZDEMİR N., KARA E., Bayraktar-Ekincioglu A., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.39, no.1, pp.291, 2017 (SCI-Expanded, Scopus) identifier

87. Evaluation of antibiotic drug interactions in intensive care unit

KARA E., Tecen K., Ozdemir N., İNKAYA A. Ç., Bayraktar-Ekincioglu A., Demirkan K., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.39, no.1, pp.290-291, 2017 (SCI-Expanded, Scopus) identifier

88. Keyif Verici Maddeler ve Antiretroviraller Keyfi dünyaya mı bedel yoksa keyfe mi keder

KARA E., İNKAYA A. Ç., DEMİRKAN S. K., ÜNAL S.
Mediterranean Journal of Infection, Microbes and Antimicrobials , vol.5, no.11, 2016 (ESCI, Scopus)

89. Recreational Drugs and Antiretrovirals: Is It Worth the World or Trivial?

KARA E., İNKAYA A. Ç., Demirkan K., ÜNAL S.
MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS , vol.5, 2016 (ESCI, Scopus) Creative Commons License Sustainable Development identifier identifier identifier
Papers Presented at Peer-Reviewed Scientific Conferences 43

1. Erişkin kistik fibrozis hastalarında meropenem ilaç düzeyi izlemi

AKMAN AR E. D., YALÇIN N., KARA E., İNKAYA A. Ç., DAMADOĞLU E., KALYONCU A. F., et al.
Türk Toraks Derneği 27. Kongresi, Girne, Cyprus (Kktc), 29 April - 03 May 2024, (Summary Text)

2. Terapötik Plazma Değişimi Sırasında Antimikrobiyal Tedavi Yönetimi: Klinik Pratiğe Yönelik Ulusal Anket Çalışması

Balaban U., Kara E., Pınar A., Özcebe O. İ., Demirkan S. K., Ünal S.
İnfeksiyon Dünyası Çalıştayı, Ankara, Turkey, 17 - 21 April 2024, pp.70-71, (Summary Text) Creative Commons License Sustainable Development

3. Terapötik Plazma Değişimi Yapılan Hastalarda İlaç Kan Düzeylerinin Potansiyel Etkilenme Durumunun Değerlendirilmesi

Balaban U., Kara E., Özcebe O. I., Demirkan S. K.
9. Ulusal Hastane ve Kurum Eczacıları Kongresi, İskele, Cyprus (Kktc), 13 - 17 December 2023, (Summary Text) Sustainable Development

4. Antimicrobial treatments during therapeutic plasma exchange: a questionnaire on practices

Balaban U., Kara E., Pınar A., Özcebe O. I., Demirkan S. K., Ünal S.
51st ESCP symposium on clinical pharmacy, Aberdeen, England, 31 October - 02 November 2023, pp.78, (Summary Text) Creative Commons License Sustainable Development

5. Antiretroviral therapy causes a reduction in T-cell exhaustion, which is preserved after switching to a new therapy regimen

Özcan B., Tavukçuoğlu E., KARA E., Horzum U., AYAN G., SÖNMEZER M. Ç., et al.
18th European AIDS Conference (EACS 2021), London, Canada, 27 October 2021, vol.1, pp.52-53, (Full Text)

6. HIV ile Yaşayan Bireylerde (PLWH) İleri Glikasyon Son Ürünleri Reseptörü (RAGE) Promotör Bölgesindeki İki Tek Nükleotid Polimorfizminin Frekansları

Mavi D., İspirli M., Şahin E. A., Kara E., Sönmezer M. Ç., Babaoğlu M. Ö., et al.
XXI. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi (KLİMİK 2021). , Antalya, Turkey, 26 - 30 May 2021, pp.947, (Summary Text) Creative Commons License Sustainable Development

7. Serbest eczacıların İnfluenza aşısına yönelik bilgi, tutum ve davranışlarının değerlendirilmesi

ÖZDEMİR N., KARA E., BÜYÜKCAM A., EKİNCİOĞLU A., ÇELİKER A., DEMİRKAN S. K., et al.
Hacettepe Üniversitesi Aşı Enstitüsü Uluslararası Katılımlı Ortak Aşı Sempozyumu, Turkey, 11 - 13 December 2020, (Summary Text)

8. Evaluation of Chronic Hepatitis B Patients’xx Knowledge About Their Disease

Bahap M., KARA E., SÖNMEZER M. Ç., İNKAYA A. Ç., DEMİRKAN S. K., ÜNAL S.
International Forum on Infectious Diseases, İstanbul, Turkey, 21 - 24 March 2019, (Summary Text) Sustainable Development

9. Evaluation of Chronic Hepatitis B Patients’ Knowledge About Their Disease

BAHAP M., KARA E., SÖNMEZER M. Ç., İNKAYA A. Ç., DEMİRKAN S. K., ÜNAL S.
International Forum on Infectious Diseases 2019 (IFID 2019), 21 - 24 March 2019 Sustainable Development

10. Drug Interactions of Echinocandins In Patients with Candidemia

KARA E., BALLI F. N., KANDEMİR E. A., İNKAYA A. Ç., ÖZYAVUZ ALP Ş., DEMİRKAN S. K.
International Forum on Infectious Diseases 2019 (IFID 2019), 21 - 24 March 2019

11. Psikiyatrist ve Enfeksiyon Hastalıkları Hekimlerinin İlaç-İlaç Etkileşimleri Konusunda Tutumları

KARA E., YALÇIN N., İNKAYA A. Ç., BAŞAR K., DEMİRKAN S. K., ÜNAL S.
HIV/AIDS Kongresi 2018, Turkey, 15 - 18 November 2018, (Summary Text)

12. Örneklerle Klinik Eczacılık Uygulamaları

KARA E., DEMİRKAN S. K.
7. Türkiye EKMUD Uluslararası Kongresi, 8 May - 13 August 2018, vol.7, pp.3, (Summary Text)

13. EVALUATION OF DRUG-DRUG INTERACTIONS OF ANTIHYPERTENSIVE DRUGS

kandemir e. a., Ballı F. N., KARA E., DEMİRKAN S. K., SAİN GÜVEN G.
12th International Symposium on Pharmaceutical Sciences (ISOPS), 26 - 29 June 2018, (Full Text)

14. Influenza vaccine: why we are not vaccinated?

Bahap M., KARA E., EKİNCİOĞLU A., DEMİRKAN S. K.
12th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Turkey, 26 - 20 June 2018, pp.90-91, (Summary Text) Sustainable Development

15. Clinical pharmacy services in internal medicine unit

Ballı F. N., Kandemir E. A., KARA E., DEMİRKAN S. K., SAİN GÜVEN G.
12th International Symposium on Pharmaceutical Sciences (ISOPS), 26 - 29 June 2018, (Full Text)

16. EVALUATION OF RATIONAL ANTIBIOTIC USE IN A CHILDREN’S HOSPITAL

ÖZDEMİR N., KARA E., BÜYÜKCAM A., AYKAÇ K., ÇELİKER A., DEMİRKAN S. K., et al.
12th International Symposium on Pharmaceutical Sciences (ISOPS), 26 - 29 June 2018, (Full Text)

17. Evaluation Of Antibiotic Use In A Children’s Hospital

ÖZDEMİR N., KARA E., BÜYÜKCAM A., AYKAÇ K., ÇELİKER A., DEMİRKAN S. K., et al.
12th International symposium on pharmaceutical science, Ankara, Turkey, 26 - 29 June 2018, (Full Text)

18. Hekimlerin Antiretroviral ve Psikotrop İlaçlar ArasındakiEtkileşimlere Yaklaşımı

YALÇIN N., KARA E., BAŞAR K., İNKAYA A. Ç., DEMİRKAN S. K., ÜNAL S.
7. Türkiye Ekmud Uluslararası Kongresi, Antalya, Turkey, 8 - 13 May 2018, (Summary Text)

19. Poliklinik ve Huzurevlerinde Değerlendirilen Yaşlı Hastalarda Aşılanma Oranları

KELLECİ ÇAKIR B., KARA E., SÜRMELİOĞLU N., BALCI C., KIZILARSLANOĞLU M. C., EKİNCİOĞLU A., et al.
7. Türkı̇ye EKMUD Uluslararası Kongresı̇, İstanbul, Turkey, 8 - 13 May 2018, vol.7, pp.26-27, (Summary Text) Sustainable Development

20. Eczacılık Fakültesi 4. Sınıf Öğrencilerinin Antibiyotik Kullanımı ve Direnci Farkındalığı

TECEN YÜCEL K., ÖZDEMİR N., KARA E., ARAS ATİK E., DEMİRKAN S. K.
7.Türkiye EKMUD Uluslararası Kongresi, Turkey, 8 - 13 May 2018, (Summary Text)

21. Çocuk Enfeksiyon Servisindeki İlaç Hatalarının Değerlendirilmesi

ÖZDEMİR N., KARA E., BAHAP M., BÜYÜKCAM A., AYKAÇ K., ARIKAN K., et al.
11. ULUSAL ÇOCUK ENFEKSİYON HASTALIKLARI KONGRESİ, Antalya, Turkey, 4 - 08 April 2018, (Summary Text)

22. Yoğun bakımda ila-ilaç etkileşimleri: nokta prevalans çalışması

Bahap M., KARA E., EKİNCİOĞLU A., DEMİRKAN S. K.
5.Ulusal Hastane ve Kurum Eczacıları Kongresi, Antalya, Turkey, 7 - 11 March 2018, pp.25, (Summary Text)

23. Evaluation of potential drug drug interactions on antiretroviral treatment

KARA E., İNKAYA A. Ç., ÖZDEMİR N., bayraktar a., DEMİRKAN S. K., ÜNAL S.
46th ESCP symposium on clinical pharmacy “Science meetspractice: towards evidence-based clinical pharmacy services”, Heidelberg, Germany, 9 - 11 October 2017, vol.40, pp.203-317, (Full Text) Creative Commons License identifier identifier

24. Evaluation Of Drugs Used İn Paediatric Bone Marrow Transplantation Unit In Terms Of Drıg İnteractions

ÖZDEMİR N., TECEN YÜCEL K., KARA E., ÇELİKER A., OKUR F. V., KUŞKONMAZ B. B., et al.
46th ESCP Symposium on Clinical Pharmacy, Heidelberg, Germany, 9 - 11 October 2017, (Summary Text)

25. Evaluation of Antibiotic Related Medication Errors in A Tertiary Children Hospital

KARA E., ÖZDEMİR N., AYKAÇ K., BÜYÜKCAM A., CANORUÇ S. D., ÇELİKER A., et al.
35th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), Madrid, Spain, 23 - 27 May 2017, (Summary Text)

26. Üçüncü Basamak Bir Hastanede Akılcı Antibiyotik Kullanımının Değerlendirilmesi

KARA E., ÖZDEMİR N., AYKAÇ K., BÜYÜKCAM A., CANORUÇ S. D., ÇELİKER A., et al.
10. Ulusal Çocuk Enfeksiyon Hastalıkları Kongresi, Turkey, 5 - 09 April 2017, (Summary Text)

27. Çocuk Hastanesinde Antibiyotik İlişkili İlaç Hatalarının Değerlendirilmesi.

KARA E., ÖZDEMİR N., AYKAÇ K., BÜYÜKCAM A., CANORUÇ S. D., ÇELİKER A., et al.
10. Ulusal Çocuk Enfeksiyon Hastalıkları Kongresi, Turkey, 5 - 09 April 2017, (Summary Text)

28. Pediatrik Kemik İliği Nakli Ünitesinde Kullanılan İlaçların İlaç Etkileşimleri Açısından Değerlendirilmesi

ÖZDEMİR N., TECEN YÜCEL K., KARA E., ÇELİKER A., OKUR F. V., KUŞKONMAZ B. B., et al.
3. Ulusal Klinik Eczacılık Farmasötik Bakım Kongresi, Antalya, Turkey, 9 - 12 February 2017, (Summary Text)

29. İlaç Etkileşimlerinin Saptanması ve Yorumlanması Çalıştayı

DEMİRKAN S. K., EKİNCİOĞLU A., KARA E., ARAS E.
3. Ulusal Klinik Eczacılık Farmasötik Bakım Kongresi, Antalya, Turkey, 9 - 12 February 2017, pp.30, (Summary Text)

30. Pediatrik Kemik İliği Nakil Ünitesinde Kullanılan İlaçların İlaç Etkileşimleri Açısından Değerlendirilmesi

ÖZDEMİR N., TECEN YÜCEL K., KARA E., ÇELİKER A., OKUR F. V., KUŞKONMAZ B. B., et al.
3. Ulusal Klinik Eczacılık Farmasötik Bakım Kongresi, Turkey, 9 - 12 February 2017, (Summary Text)

31. Evaluation of Antibiotics Drug İnteraction in Intensive Care Unit

KARA E., TECEN YÜCEL K., ÖZDEMİR N., İNKAYA A. Ç., EKİNCİOĞLU A., DEMİRKAN S. K., et al.
45th ESCP Annual Symposium Clinical pharmacy tackling inequalities and access to health care, Norway, 5 - 07 October 2016, (Summary Text)

32. Tirozin Kinaz İnhibitörü Kaynaklı Tiroid Fonksiyon Bozukluğu

TECEN K., ÖZDEMİR N., KARA E., EKİNCİOĞLU A., DEMİRKAN S. K., ERMAN M., et al.
18. ULUSAL İÇ HASTALIKLARI KONGRESİ, Turkey, 12 - 16 October 2016, (Summary Text)

33. Dislipidemi Tedavisinde Hekimlerin Kafası Karışık Mı

KARA E., ECEMİŞ S., TECEN K., UYAROĞLU O. A., ŞEYHOĞLU E., SELİMOVA C., et al.
!8. ULUSAL İÇ HASTALIKLARI KONGRESİ, Turkey, 12 - 16 October 2016, (Summary Text)

34. Evaluation of Antibiotic Drug Interactions in Intensive Care Unit

KARA E., TECEN K., ÖZDEMİR N., İNKAYA A. Ç., EKİNCİOĞLU A., DEMİRKAN S. K., et al.
45.European Symposium on Clinical Pharmacy, Oslo, Norway, 5 - 07 October 2016, vol.39, pp.290-291, (Summary Text)

35. Influence of the Clinical Pharmacy Postgraduate Program Students in Intensive Care Unit

TECEN K., SÜRMELİOĞLU N., UYSAL C., ÖZDEMİR N., KARA E., EKİNCİOĞLU A., et al.
45TH ESCP ANNUAL SYMPOSIUM CLINICAL PHARMACY, 5 - 07 October 2016, (Summary Text)

36. Drug Drug Interactions of Antibiotics and Other Drugs in Intensive Care Unit

KARA E., TECEN K., ÖZDEMİR N., İNKAYA A. Ç., EKİNCİOĞLU A., DEMİRKAN S. K., et al.
45TH ESCP ANNUAL SYMPOSIUM CLINICAL PHARMACY, 5 - 07 October 2016, (Summary Text)

37. A Major Concern Among HIV AIDS Patients Polypharmacy

KARA E., ÖZDEMİR N., TECEN K., İNKAYA A. Ç., EKİNCİOĞLU A., DEMİRKAN S. K., et al.
INTERNATIONAL WORKSHOP ON HEALTHY LIVING WITH HIV, 2 - 03 September 2016, (Summary Text) Sustainable Development

38. Klinik Eczacılık Lisansüstü Eğitim Programı Öğrencileri Tarafından Yoğun Bakım Ünitesinde Yürütülen Klinik Eczacılık Uygulamalarının Etkinliğinin Değerlendirilmesi

SÜRMELİOĞLU N., TECEN K., UYSAL C., ÖZDEMİR N., KARA E., EKİNCİOĞLU A., et al.
13. ULUSAL DAHİLİ VE CERRAHİ BİLİMLER YOĞUN BAKIM KONGRESİ, Turkey, 2 - 05 November 2016, (Summary Text)

39. Yoğun Bakım Hastalarında Antibiyotiklerin Diğer İlaçlarla Etkileşimlerinin Değerlendirilmesi

KARA E., TECEN K., ÖZDEMİR N., İNKAYA A. Ç., ÖCAL S., ORTAÇ ERSOY N. E., et al.
Hastane İnfeksiyonları Kongresi 2016, Turkey, 30 March - 03 April 2016, (Summary Text)

40. Hacettepe Üniversitesi Tıp Fakültesi Hastanesi İnfeksiyon Hastalıkları Kliniğinde İzlenen HIV olgularının yıllara göre değerlendirilmesi

kara E., İNKAYA A. Ç., ÇALIK BAŞARAN N., ÖZYAVUZ ALP Ş., TÜMER A., ÜNAL S.
İNFEKSİYON DÜNYASI ÇALIŞTAYI, Ankara, Turkey, 24 - 27 March 2016, pp.118, (Summary Text)

41. Hacettepe Üniversitesi Tıp Fakültesi Erişkin Hastanesi İnfeksiyon Hastalıkları Kliniğinde İzlenen HIV Olgularının Yıllara Göre Değerlendirilmesi

KARA E., İNKAYA A. Ç., ÇALIK BAŞARAN N., ÖZYAVUZ ALP Ş., TÜMER A., ÜNAL S.
İnfeksiyon Dünyası Çalıştayı, Turkey, 24 - 27 March 2016, (Summary Text) Sustainable Development

42. Onkoloji Hastanesi Olay Bildirimleri

ÖZDEMİR N., TECEN K., KARA E., KORUBÜK G., EKİNCİOĞLU A., DEMİRKAN S. K.
3. Ulusal Hastane ve Kurum Eczacılığı Kongresi, Turkey, 23 - 27 March 2016, (Summary Text)

43. Onkoloji Hastanesinde Kemoterapötik İlaçların İmhası

TECEN K., ÖZDEMİR N., KARA E., KORUBÜK G., EKİNCİOĞLU A., DEMİRKAN S. K.
3.Ulusal Hastane ve Kurum Eczacılığı Kongresi, Turkey, 23 - 27 March 2016, (Summary Text)
Books 6

1. Enfeksiyon Hastalıkları

KARA E., BALLI TURHAN F. N., CEYLAN C., İNKAYA A. Ç.
in: ECZACININ EL KİTABI HASTA ODAKLI ECZACILIK HİZMETLERİ VE MESLEKİ UYGULAMALAR, OKUYAN BETÜL, KARA EMRE, SANCAR MESUT, DEMİRKAN SALİH KUTAY, Editor, Güneş Tıp Kitabevleri, pp.465-492, 2025

2. KLİNİK ECZACILIK - Temel Kavramlar ve Uygulamalar

Kara E. (Editor)
Nobel Yayın Dağıtım, Ankara, 2023

3. Klinik Eczacı Danışmanlığında Terapötik İlaç İzlemi

KARA E., DEMİRKAN S. K.
in: KLİNİK ECZACILIK Temel Kavramlar ve Uygulamalar , Okuyan Betül, Kara Emre, Demirkan S. Kutay, Sancar Mesut, Editor, NOBEL AKADEMİK YAYINCILIK EĞİTİM DANIŞMANLIK TİC. LTD. ŞTİ., pp.313-326, 2023

4. ANTİMİKROBİYAL YÖNETİM PROGRAMINDA KLİNİK ECZACININ GÖREVLERİ

BAKIR EKİNCİ P., KARA E.
in: KLİNİK ECZACILIK: TEMEL KAVRAMLAR VE UYGULAMALAR , Okuyan Betül, Kara Emre, Demirkan S. Kutay, Sancar Mesut, Editor, NOBEL AKADEMİK YAYINCILIK EĞİTİM DANIŞMANLIK TİC. LTD. ŞTİ., pp.417-449, 2023

5. COVID-19’dan Korunmada ve Tedavide Kullanılabilecek Destek Ürünler

KARA E., EKİNCİOĞLU A., ÖZ Ş. G.
in: İç Hastalıkları ve COVID-19, Sain Güven G., Yıldız P., Uyaroğlu OA., Editor, Türkiye Klinikleri, Ankara, pp.40-45, 2021

6. ANTİRETROVİRAL TEDAVİ

AKALIN E. H., DEMİRKAN S. K., İNKAYA A. Ç., KAPTAN F., KARA E., SÖNMEZER M. Ç., et al.
in: HIV/AIDS TANI İZLEM VE TEDAVİ EL KİTABI, DENİZ GÖKENGİN, BEHİCE KURTARAN, VOLKAN KORTEN,FEHMİ TABAK,SERHATÜNAL, Editor, SAĞLIK BAKANLIĞI, 2019 Sustainable Development
Metrics

Publication

143

Publication (WoS)

82

Publication (Scopus)

70

Citation (WoS)

180

H-Index (WoS)

8

Citation (Scopus)

284

H-Index (Scopus)

7

Citation (Scholar)

349

H-Index (Scholar)

9

Citation (TrDizin)

16

H-Index (TrDizin)

2

Citation (Sum Other)

33

Project

1

Thesis Advisory

1

Open Access

33
UN Sustainable Development Goals